TULSA, Oklahoma – Endeavor Orthopaedics today announced the appointment of Stephen Bertz as Chief Revenue Officer (CRO), bringing more than three decades of medical device leadership, strategic growth expertise and proven success in driving revenue and market share expansion to the company’s executive team.
Bertz joins Endeavor Orthopaedics following an extensive and accomplished career at DePuy Synthes, a Johnson & Johnson company, where he most recently served as Vice President of the Southwest Area, overseeing operations across nine regions and generating well over $200 million in annual sales. Over his tenure, Bertz led high-performing teams that consistently achieved top national rankings while steering multi-billion-dollar regional portfolios through transformational integrations, mergers and go-to-market realignments.
“Stephen’s deep industry expertise, leadership integrity and visionary approach to commercial excellence make him an outstanding addition to our executive team,” said Greg Parranto, CEO of Endeavor Orthopaedics. “His ability to scale growth, inspire teams and build lasting relationships across the healthcare ecosystem aligns perfectly with our mission to deliver innovation and value to surgeons and patients alike.”
Throughout his 30-year career in the orthopaedic and medical device industry, Bertz has earned a reputation as a strategic thinker and results-driven leader. His strengths include sales strategy, product marketing, change management, talent development and enterprise integration. During his time at DePuy Synthes, he played a key leadership role in the integration of Synthes into Johnson & Johnson’s DePuy franchise, one of the largest integrations in J&J history, while sustaining category-leading growth in Joint Reconstruction, Trauma, Sports, biologics and CMF in both direct and indirect sales channels.
Before joining DePuy Synthes, Bertz began his career at Stryker Corporation, where he quickly advanced through roles in sales and product management, ultimately overseeing marketing and product development for Stryker’s Dental Division.
“I’m honored to join Endeavor Orthopaedics at such a pivotal time in its growth,” said Bertz. “This is a company that combines innovation, integrity and patient-centered excellence. I look forward to partnering with our teams to expand our reach, strengthen our partnerships and accelerate growth across all business segments.”
Bertz earned his Bachelor of Arts in Economics from Occidental College in Los Angeles where he also served on the Presidential Advisory Proxy Committee and as a Charles R. Blythe Fund Director.
About Endeavor Orthopaedics
Headquartered in Tulsa, Oklahoma, Endeavor Orthopaedics focuses on the treatment and advancement of solutions for fractures in which bony fragment remains tethered to a tendon or ligament through its patented technology platform. The company's first FDA-cleared product, the SummitTM Patella Plating System, is the only patella plating system with built-in soft tissue management. It is provided in a single-use sterile procedure kit and launched in 2023.
---
Media Relations Contact
Dana J Funk, Chief Operations Officer
dfunk@endeavorortho.com
